Printed delivery devices are disclosed herein. In some embodiments, a printed delivery device (100) includes a support substrate. A first printed composition (102), including a first supplement, is coated onto the support substrate (202) and a second printed composition (102) disposed on the first printed composition. A decorative film is applied to one or more of the first printed composition, second printed composition, or the support substrate (602).

A process for producing food having fried organoleptic properties with low oil content such as instant noodles with good aroma, taste, mouthfeel, colour and other characteristics by incorporating an antioxidant into the dough and cooking it in a stream of circulated air at a temperature of 100° C. or above.

A process for producing food having fried organoleptic properties with low oil content such as instant noodles with good aroma, taste, mouthfeel, colour and other characteristics by incorporating an antioxidant into the dough and cooking it in a stream of circulated air at a temperature of 100° C. or above.

The present disclosure relates to a method for preventing, alleviating, improving or treating female hormone regulation disorder or symptoms, which contains a green tea extract with contents of ingredients changed. Specifically, the method according to an aspect of the present disclosure includes a step of administering an effective amount of a green tea extract, which contains (−)-gallocatechin gallate (GCG) and (−)-epigallocatechin gallate (EGCG) at specific contents, to a subject in need thereof, and may exhibit an effect of preventing, alleviating, improving or treating female hormone regulation disorder or symptoms.

The present disclosure relates to a method for preventing, alleviating, improving or treating female hormone regulation disorder or symptoms, which contains a green tea extract with contents of ingredients changed. Specifically, the method according to an aspect of the present disclosure includes a step of administering an effective amount of a green tea extract, which contains (−)-gallocatechin gallate (GCG) and (−)-epigallocatechin gallate (EGCG) at specific contents, to a subject in need thereof, and may exhibit an effect of preventing, alleviating, improving or treating female hormone regulation disorder or symptoms.

The invention relates to compositions comprising complexes of α-cyclodextrin and cannabinoids and/or complexes of α-cyclodextrin and terpenes, methods of making these α-cyclodextrin and cannabinoid complex-containing compositions, and methods of using the α-cyclodextrin and cannabinoid complex-containing compositions. The invention also relates to food products comprising the α-cyclodextrin and cannabinoid complex-containing compositions of this invention.

The invention relates to compositions comprising complexes of α-cyclodextrin and cannabinoids and/or complexes of α-cyclodextrin and terpenes, methods of making these α-cyclodextrin and cannabinoid complex-containing compositions, and methods of using the α-cyclodextrin and cannabinoid complex-containing compositions. The invention also relates to food products comprising the α-cyclodextrin and cannabinoid complex-containing compositions of this invention.

The current invention provides a composition for use in the treatment, suppression and/or prevention of viral infections of the Asfaraviridae and the spreading thereof, preferably African Swine Fever virus, characterized in that said composition comprises one or more medium-chain fatty acids (MCFAs) and/or derivatives thereof.

The current invention provides a composition for use in the treatment, suppression and/or prevention of viral infections of the Asfaraviridae and the spreading thereof, preferably African Swine Fever virus, characterized in that said composition comprises one or more medium-chain fatty acids (MCFAs) and/or derivatives thereof.

This angiotensin-converting enzyme inhibitor and this blood pressure-lowering agent contain a compound represented by formula (I) as an active ingredient. These beverages and food products for inhibiting an angiotensin-converting enzyme and these beverages and food products for lowering blood pressure are characterized by containing a compound represented by formula (I). As a result, provided are an angiotensin-converting enzyme inhibitor and blood pressure-lowering agent that have an excellent angiotensin-converting enzyme-inhibiting effect and blood pressure-lowering effect. Furthermore, provided are beverages and food products suitable for inhibition of an angiotensin-converting enzyme and lowering of blood pressure.

##STR00001##